Treatment of DIC with Primary Hyperfibrinolytic State and Severe Bleeding
This protocol addresses disseminated intravascular coagulation (DIC) in the specific clinical presentation of a primary hyperfibrinolytic state accompanied by severe bleeding.
The scenario involves DIC in which the dominant feature is a primary hyperfibrinolytic state presenting with severe bleeding — a pattern that calls for a targeted therapeutic strategy.
Treatment approach
Management involves antifibrinolytic therapy using a specific class of lysine analogues. The complete regimen, dosing guidance, and evidence grading are available in the full protocol.
References
DOI: 10.1111/j.1365-2141.2009.07600.x
Patients with DIC that is characterized by a primary hyperfibrinolytic state and who present with severe bleeding could be treated with lysine analogues, such as tranexamic acid (e.g. 1 g every 8 h) (Grade C, Level IV).
View source ↗